戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nthetic genome that can be used to produce a synthetic cell.
2  and opening up its use in the generation of synthetic cells.
3 romolecular machines, metabolic networks and synthetic cells.
4 esting, biophysical studies and their use as synthetic cells.
5 crodroplets are finding increased utility in synthetic cell applications due to their cytomimetic pro
6                                            A synthetic cell-binding peptide (P-15) combined with anor
7                                            A synthetic cell-binding peptide (P-15) combined with anor
8                                The role of a synthetic cell-binding peptide (P-15), combined with ano
9 ese results suggest that the use of the P-15 synthetic cell-binding peptide combined with ABM yields
10 ese results suggest that the use of the P-15 synthetic cell-binding peptide combined with ABM yields
11 erived hydroxyapatite matrix combined with a synthetic cell-binding peptide P-15 (Putty P15) to deter
12 ith a bovine-derived xenograft coated with a synthetic cell-binding peptide; then the test group rece
13                          The construction of synthetic cell-cell communication networks can improve o
14 mic control over protein distribution within synthetic cells comprising a lipid bilayer membrane surr
15 , we pave the way for the development of new synthetic cell constructs.
16 oluble Abeta oligomers from several sources (synthetic, cell culture, human brain extracts) facilitat
17 olling a wide range of in vitro chemistries, synthetic cell-free biochemical circuits promise to be u
18 port here on the development of a completely synthetic cell-free therapy based on peptide amphiphile
19 ith good spatial and temporal control within synthetic, cell-laden biomimetic scaffolds.
20 w available to generate rudimentary forms of synthetic cell-like entities, minimal progress has been
21  controlled drug release and the building of synthetic cell-like or logic ionic networks.
22                         Here, we fabricate a synthetic cell-mimicking microparticle (CMMP) that recap
23  a simple method for the de novo creation of synthetic cell mimics in the form of giant polymeric ves
24 ent work and challenges in developing these "synthetic cell" models and their growing practical appli
25 assive simulations of particles diffusing in synthetic cells parameterized by morphometric statistics
26                                              Synthetic cell permeable C2-ceramide induced apoptotic d
27 in/TCF-dependent transcription, we developed synthetic cell-permeable analogs of beta-catenin's helix
28 ence of N-acetylsphingosine (C2-ceramide), a synthetic cell-permeable ceramide analog.
29                                              Synthetic cell-permeable ceramides (C6- and C2-ceramide)
30 ules that can be oligomerized in vivo by the synthetic cell-permeable dimerizer FK1012H2.
31 urthermore, treating BMECs with cavtratin, a synthetic cell-permeable peptide encoding the caveolin-1
32 3-methyl-but-2-enyl diphosphate (HMBPP) or a synthetic cell-permeable prodrug, bis (pivaloyloxymethyl
33 everal families of readily prepared, totally synthetic, cell-permeable dimerizers composed of ligands
34 s available, control of gene expression with synthetic, cell-permeable molecules is within reach.
35 nto IGCs, and addition of a newly developed, synthetic, cell-permeable P/CAF inhibitor blocks this mo
36            These findings demonstrate that a synthetic, cell-permeable small-molecule can be develope
37                 Here we report the design of synthetic, cell-permeable, stabilized alpha-helical pept
38 ever, recent progress toward the creation of synthetic cells, ranging from simple protocells to artif
39                                              Synthetic cell surface receptors have potential applicat
40 emonstrate the first production of a totally synthetic cell-surface receptor for a virus.
41                           This method yields synthetic cells (tentatively neurons and astrocytes) tha
42                                 To produce a synthetic cell, the genome must be transferred from yeas
43                                            A synthetic cell-wall analogue was developed to hijack the
44 structures of the enzyme in complex with two synthetic cell-wall-based ligands, we present for the fi
45 e catalytic domain of LytA in complex with a synthetic cell-wall-based peptidoglycan (PG) ligand that
46 ng the genetic code converged when the first synthetic cell was created 4 years ago.
47                                The origin of synthetic cells was further examined by colocalization o
48  illustrate an approach for the evolution of synthetic cells with alternative biochemical building bl

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。